Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C P Day

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Journal of Hepatology|March 29, 2000
Stress-activated protein kinases in the activation of rat hepatic stellate cells in cultureH L Reeves, C L Dack, M Peak, et al.
Hepatology (Baltimore, Md.)|July 1, 1993
Alcohol dehydrogenase polymorphisms and predisposition to alcoholic cirrhosisC P Day, O F James, M F Bassendine, et al.
Hepatology (Baltimore, Md.)|December 1, 1995
The natural history of nonalcoholic fatty liver: a follow-up studyM R Teli, O F James, A D Burt, et al.
Hepatology (Baltimore, Md.)|December 29, 1999
The role of phosphatidic acid in platelet-derived growth factor-induced proliferation of rat hepatic stellate cellsH L Reeves, M G Thompson, C L Dack, et al.
Lancet (London, England)|October 14, 1995
Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liverM R Teli, C P Day, A D Burt, et al.
Journal of Hepatology|November 1, 1992
No evidence for involvement of type 1 collagen structural genes in 'genetic predisposition' to alcoholic cirrhosisR Bashir, C P Day, O F James, et al.
Diabetologia|April 30, 1998
Tumour necrosis factor-alpha gene promoter polymorphism and decreased insulin resistanceC P Day, J Grove, A K Daly, et al.
Pharmacogenetics|September 10, 1998
The RsaI polymorphism of CYP2E1 and susceptibility to alcoholic liver disease in Caucasians: effect on age of presentation and dependence on alcohol dehydrogenase genotypeJ Grove, A S Brown, A K Daly, et al.
Digestive Diseases and Sciences|August 2, 2001
Role of polymorphisms in the interleukin-10 gene in determining disease susceptibility and phenotype in inflamatory bowel diseaseG P Aithal, A Craggs, C P Day, et al.
Gut|September 1, 1995
Ranitidine increases the bioavailability of postprandial ethanol by the reduction of first pass metabolismA S Brown, J R Fiaterone, C P Day, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Journal of Hepatology|March 29, 2000
Stress-activated protein kinases in the activation of rat hepatic stellate cells in cultureH L Reeves, C L Dack, M Peak, et al.
Hepatology (Baltimore, Md.)|July 1, 1993
Alcohol dehydrogenase polymorphisms and predisposition to alcoholic cirrhosisC P Day, O F James, M F Bassendine, et al.
Hepatology (Baltimore, Md.)|December 1, 1995
The natural history of nonalcoholic fatty liver: a follow-up studyM R Teli, O F James, A D Burt, et al.
Hepatology (Baltimore, Md.)|December 29, 1999
The role of phosphatidic acid in platelet-derived growth factor-induced proliferation of rat hepatic stellate cellsH L Reeves, M G Thompson, C L Dack, et al.
Lancet (London, England)|October 14, 1995
Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liverM R Teli, C P Day, A D Burt, et al.
Journal of Hepatology|November 1, 1992
No evidence for involvement of type 1 collagen structural genes in 'genetic predisposition' to alcoholic cirrhosisR Bashir, C P Day, O F James, et al.
Diabetologia|April 30, 1998
Tumour necrosis factor-alpha gene promoter polymorphism and decreased insulin resistanceC P Day, J Grove, A K Daly, et al.
Pharmacogenetics|September 10, 1998
The RsaI polymorphism of CYP2E1 and susceptibility to alcoholic liver disease in Caucasians: effect on age of presentation and dependence on alcohol dehydrogenase genotypeJ Grove, A S Brown, A K Daly, et al.
Digestive Diseases and Sciences|August 2, 2001
Role of polymorphisms in the interleukin-10 gene in determining disease susceptibility and phenotype in inflamatory bowel diseaseG P Aithal, A Craggs, C P Day, et al.
Gut|September 1, 1995
Ranitidine increases the bioavailability of postprandial ethanol by the reduction of first pass metabolismA S Brown, J R Fiaterone, C P Day, et al.
Pageof 9